Skip to content

Clinical Trials

Academic Thoracic Oncology Medical Investigators Consortium (ATOMIC)

Clinical Trials

Criterium and The Oncology Consortia of Criterium are currently collaborating with our investigators and leading pharmaceutical partners on a number of exciting trials.

The following are clinical trials conducted by ATOMIC member and affiliate sites. Please click on the link in each listing to view the trial information at 

EGFR-Mutant, T790M-Negative, Advanced NSCLC / Ph II
A clinical study to evaluate antitumor activity as determined by response rate in patients with EGFR-mutant, T790M-negative, advanced NSCLC progressing on an EGFR TKICancer

Refractory ALK Rearranged NSCLC / Ph II
Trial of Brigatinib After Treatment With Second-Generation ALK Inhibitors
Clinical Trial ID NCT02706626